Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders
Authors:
- 25 April 2010
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 149 (4) , 465-477
Abstract
Hypercalcaemia is a common metabolic complication of malignant disease often requiring emergency intervention. Although it is more frequently associated with solid tumours, malignancy-associated hypercalcaemia (MAH) is seen in a significant number of patients with blood diseases. Its association with myeloma and adult T-cell leukaemia/lymphoma is well recognized but the incidence of hypercalcaemia in other haematological neoplasms, affecting adults and children, is less clearly defined. Haematologists need to be familiar with the clinical manifestations of, the differential diagnosis to be considered and the most effective management strategies that are currently available for MAH. The key components of management of MAH include aggressive rehydration, specific therapy to inhibit bone resorption and, crucially, treatment of the underlying malignancy. Bisphosphonates have revolutionized the management of MAH over the last 20 years, however the elucidation of molecular pathways implicated in MAH is facilitating the development of more targeted approaches to treatmentKeywords
This publication has 88 references indexed in Scilit:
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and DiseaseEndocrine Reviews, 2007
- Adult T-cell leukaemia/lymphomaJournal of Clinical Pathology, 2007
- Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NF-κB in adult T-cell leukemia/lymphomaLeukemia, 2007
- Multiple myeloma/hypercalcemiaArthritis Research & Therapy, 2007
- Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to boneEndocrine-Related Cancer, 2005
- Hypercalcemia Associated with CancerNew England Journal of Medicine, 2005
- Comparative Tolerability of Drug Therapies for Hypercalcaemia of MalignancyDrug Safety, 1999
- Parathyroid Hormone-Related Protein in Hypercalcemia Associated with Hematological MalignancyLeukemia & Lymphoma, 1998
- Hypercalcemia may indicate Richter's syndromeCancer, 1997